[go: up one dir, main page]

AU2003242590A1 - Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use - Google Patents

Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use

Info

Publication number
AU2003242590A1
AU2003242590A1 AU2003242590A AU2003242590A AU2003242590A1 AU 2003242590 A1 AU2003242590 A1 AU 2003242590A1 AU 2003242590 A AU2003242590 A AU 2003242590A AU 2003242590 A AU2003242590 A AU 2003242590A AU 2003242590 A1 AU2003242590 A1 AU 2003242590A1
Authority
AU
Australia
Prior art keywords
processes
preparation
high purity
crystalline hydrate
hydrate forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242590A
Inventor
Anton Copar
Borut Furlan
Zoran Ham
Uros Urleb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Publication of AU2003242590A1 publication Critical patent/AU2003242590A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2003242590A 2002-05-31 2003-05-28 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use Abandoned AU2003242590A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SIP-200200141 2002-05-31
SI200200141A SI21233A (en) 2002-05-31 2002-05-31 High purity crystalline hydrate forms of amlodipine benzensulphonate, methods of their preparation and usage
PCT/EP2003/005632 WO2003101965A1 (en) 2002-05-31 2003-05-28 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use

Publications (1)

Publication Number Publication Date
AU2003242590A1 true AU2003242590A1 (en) 2003-12-19

Family

ID=29708005

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242590A Abandoned AU2003242590A1 (en) 2002-05-31 2003-05-28 Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use

Country Status (3)

Country Link
AU (1) AU2003242590A1 (en)
SI (1) SI21233A (en)
WO (1) WO2003101965A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037565A1 (en) 2001-11-21 2004-11-17 Synthon Bv FORMS OF AMLODIPINE SALTS AND PROCEDURES TO PREPARE THEM.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (en) * 1992-11-26 1998-06-30 Lek, A process for the preparation of amlodipine benzenesulfonate

Also Published As

Publication number Publication date
WO2003101965A1 (en) 2003-12-11
SI21233A (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2002343784A1 (en) Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2002332638A1 (en) Method for the preparation of crystalline tetrahydrobenzothiepines
WO2004113292A3 (en) Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
AU2002259025A1 (en) Reforming process for manufacture of para-xylene
HUP0402129A3 (en) Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives, preparation thereof, compositions containing the same and processes for their use
PL368984A1 (en) Process for the preparation of crystalline imipenem
AU2002343257A1 (en) Amlodipine salt forms and processes for preparing them
AU2003208595A1 (en) Process for the preparation of pure silica
AU2003217482A1 (en) High purity titanium oxide and production process thereof
AU2003285625A1 (en) Pure levofloxacin hemihydrate and processes for preparation thereof
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
AU2003218704A1 (en) Process for preparing 2-aminoindan derivatives
AU2003242590A1 (en) Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use
AU2003260078A1 (en) Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2003287844A1 (en) Novel crystalline forms of entacapone, and production thereof
AU2002322883A1 (en) Insulating inserts for elevated temperature process vessels
AU2003225426A1 (en) Process for the preparation of urea
AU2003219507A1 (en) Process for the preparation of highly pure torsemide
AU2003300874A1 (en) Crystalline forms of gatifloxacin and processes for preparation
AU2002247949A1 (en) Process for synthesis of trans-alkenoic acid, use thereof
AU2003256006A1 (en) Improved process for preparation of risperidone
AU2003219423A1 (en) Process for the isolation of high purity crystalline citalopram base

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase